A Study of Nilotinib Versus Imatinib in GIST Patients

Clinical trial NCT00785785 · COMPLETED

Trial details

NCT number: NCT00785785
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumor (GIST)

Start date: 2009-03-01
Primary completion: 2014-10-01
Enrollment: 644

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.